- Previous Close
5.80 - Open
6.00 - Bid 5.60 x --
- Ask 5.95 x --
- Day's Range
5.50 - 6.10 - 52 Week Range
1.01 - 6.50 - Volume
22,243 - Avg. Volume
11,615 - Market Cap (intraday)
26.904M - Beta (5Y Monthly) 2.04
- PE Ratio (TTM)
-- - EPS (TTM)
-0.59 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 16, 2021
- 1y Target Est
--
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024. Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden.
perpetuamedical.seRecent News: PERP-B.ST
View MorePerformance Overview: PERP-B.ST
Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PERP-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PERP-B.ST
View MoreValuation Measures
Market Cap
26.23M
Enterprise Value
21.45M
Trailing P/E
2.85
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.99
Price/Book (mrq)
2.87
Enterprise Value/Revenue
4.02
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-134.28%
Return on Assets (ttm)
-35.42%
Return on Equity (ttm)
-74.21%
Revenue (ttm)
6.32M
Net Income Avi to Common (ttm)
-8.48M
Diluted EPS (ttm)
-0.59
Balance Sheet and Cash Flow
Total Cash (mrq)
8.9M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
9.86M